dovepress.com
Cure8 news brief
C-Reactive Protein for Predicting Intestinal Resection in Crohn's Dise - Dove Medical Press
Tests and monitoring
Biomarkers
CRP
Fecal calprotectin
Bowel Resection
Colectomy
Diarrhea
Weight Loss
Why This Matters
A simple blood test (CRP) that's already used in IBD care might help predict which Crohn's patients with C. difficile coinfection are more likely to need intestinal surgery, enabling earlier attention or monitoring.
Who Should Pay Attention
Adults with Crohn's disease (especially those with C. difficile infection), gastroenterologists/IBD clinicians, and researchers studying biomarkers or postoperative risk.
Study Snapshot
Story typeResearch paper
Evidence typeClinical study
Source depthFull source text
What To Know
This is a single‑center retrospective cohort study of Crohn’s disease patients who developed C. difficile infection. The authors measured CRP at CDI diagnosis and analyzed its association with subsequent intestinal resection during follow‑up.
The paper situates CRP as a widely available serum biomarker and compares it to other markers (fecal calprotectin, albumin, NLR) discussed in the text. The study’s design is retrospective and single‑center, which affects generalizability and causality.
The article focuses on prognostic association (risk stratification), not testing interventions that alter CRP or prevent surgery.
Keep In Mind
Retrospective, single‑center design limits generalizability; CRP is a nonspecific inflammatory marker and may reflect combined effects of CD activity and CDI. Validation in larger prospective studies would be needed before changing clinical practice.
Source Details
Review the original publication for the complete reporting, methods, and context.
Clinical study
Article type assigned from Cure8 classification; confirm details in the original source.
Publicationdovepress.com
Indexed viaGoogle News
Source typeWeb article
PublishedOct 22, 2026, 12:48 PM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
The study tests whether adding MRI-based transmural assessment to a fecal-calprotectin–guided (CALM) strategy improves the ability to keep people with Crohn’s disease in corticosteroid-free clinical remission and may...
Preventing Postsurgical Crohn's Recurrence - Everyday Health
After bowel resection, Crohn’s often returns quietly at the surgical join (anastomosis). Early, planned monitoring can detect inflammation before symptoms appear and help prevent symptomatic recurrence or repeat surgery.
Celltrion To Present ZYMFENTRA Data On Treatment Resumption And Crohn's Outcomes At ACG 2026
Conference analyses describe how subcutaneous infliximab performs after stopping IV treatment and when compared with IV infliximab for ileal/ileocolonic Crohn's — information that could affect treatment decisions for...